RISE registry reveals potential gaps in medication safety for new users of biologics and targeted synthetic DMARDs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RISE registry reveals potential gaps in medication safety for new users of biologics and targeted synthetic DMARDs

Published:2020-12 Issue:6 Volume:50 Page:1542-1548
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Schmajuk Gabriela^ORCID,Li Jing,Evans Michael,Anastasiou Christine^ORCID,Izadi Zara,Kay Julia L.,Hammam Nevin,Yazdany Jinoos

Funder

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Agency for Healthcare Research and Quality

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference23 articles.

1. 2012 update of the 2008 American college of rheumatology recommendations for the use of disease modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis;Singh;Arthritis Care Res,2012

2. Preventing hepatitis b reactivation due to immunosuppressive drug treatments;Perrillo;JAMA,2015

3. Tuberculosis associated with blocking agents against tumor necrosis factor-alpha–California, 2002-2003;MMWR Morb Mortal Wkly Rep,2004

4. Gaps in ambulatory patient safety for immunosuppressive specialty medications;Patterson;Jt Comm J Qual Patient Saf,2019

5. Using health-system-wide data to understand hepatitis B virus prophylaxis and reactivation outcomes in patients receiving rituximab;Schmajuk;Medicine (Baltimore),2017

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. National rollout of a medication safety dashboard to improve testing for latent infections among biologic and targeted synthetic disease‐modifying agent users within the Veterans Health Administration;Health Services Research;2024-07-26

2. Latent Tuberculosis Screening Among New Users of a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug: Gaps in Screening Overall and Among Janus Kinase Inhibitors;Arthritis Care & Research;2024-03-18

3. Implementation of a Best Practice Advisory to Improve Infection Screening Prior to New Prescriptions of Biologics and Targeted Synthetic Drugs;Arthritis Care & Research;2023-08-29

4. Chronic viral hepatitis B and rheumatic diseases: Modern view on problem;Medical alphabet;2022-12-25

5. Screening for Latent Infections Among Users of High-Risk Immunosuppressants: A Cross-Sectional Analysis From the Veterans Health Administration Healthcare System;Journal of Patient Safety;2022-11-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3